StimCytes™ BCMA
Precision engineered synthetic cell mimics designed to support CAR‑T potency assessment through targeted BCMA specific activation, cytokine release and biomarker driven assay development.
Place your order directly with the manufacturer.
StimCytes™ BCMA are cryopreserved human B cell maturation antigen (BCMA) positive cells designed to support the development and optimization of BCMA-targeted assays. These ready-to-use cells provide a consistent, reliable control material for researchers working on immunotherapy, cell therapy, and flow cytometry applications.
Product overview
StimCytes™ BCMA are manufactured from human cells that have been stimulated to express B cell maturation antigen on the cell surface. Each lot is cryopreserved to maintain stability and performance, enabling reproducible results across experiments and over time.
Application and workflow compatibility
These BCMA-positive cells are suitable for use as controls in assay development, qualification, and routine monitoring. StimCytes™ BCMA integrate seamlessly into existing laboratory workflows, including flow cytometry panels and other BCMA expression analyses, helping to streamline method development and reduce variability.
Quality, consistency, and convenience
StimCytes™ BCMA are produced under controlled conditions to deliver consistent BCMA expression and cell quality from vial to vial. The cryopreserved format allows flexible scheduling of experiments, minimizes preparation time, and supports standardized assay performance across teams and sites.
Key features and benefits of StimCytes™ BCMA:
- Human B cell maturation antigen positive cells for BCMA-targeted assay support
- Cryopreserved format for long-term storage and on-demand use
- Consistent BCMA expression to enhance assay reproducibility
- Compatible with flow cytometry and other BCMA expression workflows
- Streamlines assay development, qualification, and routine control testing
